About This Stock More About This StockReadReadReadRead
Article By: ValueWalk
Tuesday, January 31, 2017 9:06 AM EST
Pfizer reported GAAP earnings of 13 cents per share, swinging from a loss of 3 cents per share in the year-ago quarter. Innovative Health revenues rose 1% to $7.7 billion, while Essential Health sales declined 8% to $5.9 billion.
Article By: Zacks Investment Research
Monday, January 30, 2017 9:46 AM EST
Eli Lilly’s bottom-line performance has been mixed so far, with its earnings surpassing expectations in two of the last four quarters, and missing the same in the other two, bringing the average negative surprise to 2.05%.